* USANA Health Sciences Inc USNA.N reported quarterly
adjusted
earnings of 59 cents per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of 64 cents per share.
* Revenue fell 8.5% to $213.37 million from a year ago;
analysts
expected $220.41 million.
* USANA Health Sciences Inc's reported EPS for the quarter
was 59
cents.
* The mean earnings estimate of analysts had fallen by
about 6.8%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* USANA Health Sciences Inc shares had fallen by 6.9% this
quarter and gained 2.6% so far this year.
* The company reported quarterly net income of $11.35
million.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $68.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
October 24 at 09:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.64 0.59 Missed
Jun. 30 2023 0.70 0.89 Beat
Mar. 31 2023 0.77 0.95 Beat
Dec. 31 2022 0.35 0.66 Beat